agilon health, inc.
AGL
$0.42
-$0.02-4.12%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -50.43% | 19.89% | -5.71% | 9.69% | -5.82% |
| Total Depreciation and Amortization | 6.67% | -22.40% | -20.20% | 2.33% | 7.42% |
| Total Amortization of Deferred Charges | 30.48% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 42.68% | -101.17% | -82.08% | -79.13% | -45.88% |
| Change in Net Operating Assets | 45.09% | 76.48% | 513.05% | 302.36% | 1,153.25% |
| Cash from Operations | -83.05% | 49.17% | 58.52% | 70.67% | 63.01% |
| Capital Expenditure | 0.07% | 2.71% | 3.95% | -25.12% | -12.91% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -33.49% | -18.40% | 89.00% | 65.09% | 1,754.52% |
| Cash from Investing | -36.66% | -21.33% | 108.45% | 12.25% | 417.80% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 75.00% | 33.33% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -85.70% |
| Repurchase of Common Stock | -- | 96.45% | 61.64% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -15.91% | 11.95% | -606.61% | 98.36% | 98.66% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -125.33% | 172.29% | 164.92% | 107.02% | 120.22% |